Ohm,
Thanks !!! very interesting. That leaves CCR5 as the king of the hill, so to speak.
All the roads are converging to Rome …. and we seem to be there already.
We will see the clinical outcomes confirm this.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-